Related Experiment Video
Updated: Aug 9, 2026

The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse
Published on: July 25, 2011
[Are statins indicated in the prevention of cerebral infarct?]
E Díez-Tejedor1, J A Egido Herrero, A C Gil Núñez
1Hospital Universitario La Paz, Madrid.
Insights
Pravastatin may reduce strokes in patients with ischemic cardiopathy. Further clinical trials are needed, but current evidence suggests its use in stroke prevention for specific patient groups.
Area of Science:
- Cardiology
- Neurology
- Pharmacology
Context:
- Ischemic cardiopathy and stroke share common risk factors, including dyslipidemia and atherosclerosis.
- Statins, like pravastatin, are known for their lipid-lowering effects and potential pleiotropic benefits.
- Expert review of existing data on dyslipidemia, stroke epidemiology, and statin mechanisms.
Purpose:
- To evaluate the potential role of pravastatin in stroke prevention for patients with ischemic cardiopathy.
- To assess the efficacy of statins in preventing cerebral infarcts in patients with carotid artery stenosis.
- To discuss the mechanism of action of statins in this context.
Summary:
- Studies suggest pravastatin use in ischemic cardiopathy may reduce stroke incidence.
- Expert panel reviewed data on dyslipidemias, stroke epidemiology, and statin effects on cerebral infarcts.
- Pravastatin is recommended for primary stroke prevention in atheromatous stroke patients, those with stroke and hypercholesterolemia, and carotid stenosis.
Impact:
- Pravastatin may offer a therapeutic option for primary stroke prevention in specific high-risk populations.
- Highlights the need for further clinical trials to confirm pravastatin's role in stroke prevention.
- Informs clinical practice regarding statin use in patients with cerebrovascular and cardiovascular risk factors.
Introduction:
Some studies of ischemic cardiopathy have shown that when pravastatin is used for the prevention of strokes, these are reduced. Whilst we await suitable clinical trials, we discuss the possible role played by these drugs in this subgroup of patients.
Development:
A panel of experts from different specialties assess the data published on dislipemias in the epidemiology of strokes, the possible effect of statins in the prevention of cerebral infarcts in patients with atheromatous stenosis of the carotid artery and their mode of action.
Conclusions:
Pravastatin is indicated in all patients with ictus of atheromatous origin as primary prevention of ischemic cardiopathy, in patients with strokes and hypercholesterolemia, and in patients with symptomatic or asymptomatic carotid stenosis while we wait for more specific clinical trials.
More Related Videos
09:11Performing Permanent Distal Middle Cerebral with Common Carotid Artery Occlusion in Aged Rats to Study Cortical Ischemia with Sustained Disability
Published on: February 23, 2016
10:13Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia
Published on: July 31, 2017
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease IV: Preventive Measures
Angina IV: Management
Atherosclerosis III: Management
Ischemic Stroke l: Introduction